Mortality Experience of a Low-Income Population With Young-Onset Diabetes
Open Access
- 10 February 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (3) , 542-548
Abstract
OBJECTIVE: In young-onset diabetes, insulin therapy status is a rough marker of diabetes type. We describe the mortality experience of a low-income, predominantly minority population with diabetes diagnosed before age 30 years, stratified by insulin therapy. RESEARCH DESIGN AND METHODS: A total of 1,098 adults aged 40–79 years (median 49) diagnosed with diabetes before age 30 years and 49,914 without diabetes were recruited from community health centers. Individuals with diabetes were categorized by insulin therapy at baseline: group A, insulin therapy only; group B, insulin therapy and an oral hypoglycemic agent; and group C, no insulin therapy. Cox models were used to compute hazard ratios (HRs) and 95% CI for cause-specific mortality based on both underlying and contributing causes of death from death certificates. RESULTS: During follow-up (mean 3.9 years), 15.0, 12.5, and 7.3% of groups A, B, and C, respectively, and 4.6% without diabetes died. Compared with individuals without diabetes, HRs (CI) for all-cause mortality were 4.3 (3.4–5.6), 4.2 (2.8–6.3), and 2.0 (1.4–2.8) in groups A, B, and C, respectively. The leading cause of death was renal failure (end-stage renal disease [ESRD]) in group A, ESRD and coronary artery disease (CAD) in group B, and CAD in group C and individuals without diabetes. HRs for these conditions were at least twice as high as the HRs for all-cause mortality, reaching 17.3 (10.2–29.3), 17.9 (8.3–38.7), and 5.1 (2.3–11.7) in groups A, B, and C, respectively, for ESRD. CONCLUSIONS: Excess mortality persists among people with young-onset diabetes of long duration, with ESRD and CAD as the leading contributors to mortality.Keywords
This publication has 41 references indexed in Scilit:
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- The 25-Year Cumulative Incidence of Lower Extremity Amputations in People With Type 1 DiabetesDiabetes Care, 2011
- Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 DiabetesDiabetes, 2010
- In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications StudyDiabetologia, 2010
- The Southern Community Cohort Study: Investigating Health DisparitiesJournal Of Health Care For The Poor and Underserved, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Genome-Wide Linkage Scan for Genes Influencing Plasma Triglyceride Levels in the Veterans Administration Genetic Epidemiology StudyDiabetes, 2009
- Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youthsPediatric Diabetes, 2007
- Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetesJournal of Autoimmunity, 2005
- Type 2 diabetes among North adolescents: An epidemiologic health perspectiveThe Journal of Pediatrics, 2000